Neolife SAS (8JB) Stock Statistics & Valuation Metrics

Neolife SAS has a market cap or net worth of €5.78M. The enterprise value is ―.

Neolife SAS has 96,370,850 shares outstanding. The number of shares has decreased by -2.65% in one year.

Neolife SAS’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 10.31%.

The current PE Ratio of Neolife SAS is 24.5. Neolife SAS’s PEG ratio is -0.07.

In the last 12 months, Neolife SAS had revenue of 12.17M and earned 473.00K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was ― and capital expenditures 0.00, giving a free cash flow of ― billion.

Neolife SAS pays an annual dividend of ―, resulting in a dividend yield of ―

Neolife SAS upcoming earnings date is ―, ―.

Neolife SAS as a current ratio of 1.47, with Debt / Equity ratio of 18.46%

In the past 12 months, Neolife SAS has paid -109.00K in taxes.

Neolife SAS EV to EBITDA ratio is 4.50, with an EV/FCF ratio of 2.74K.

Neolife SAS has €1.05M in cash and marketable securities with €1.48M in debt, giving a net cash position of -€436.87K billion.

Gross margin is 2.87%, with operating margin of 3.81%, and net profit margin of 3.89%.

The average price target for Neolife SAS is ―, which is 11.43% higher than the current price. The consensus rating is ―